ALBANY, New York, February 21, 2018 /PRNewswire/ -- According to the report, the global radiation dose management market was estimated at US$1,432.0 mn in 2016 and is expected to expand at an impressive CAGR of 9.1% from 2017 to 2025, rising to an estimated value of US$3,066.1 mn in 2025.
Increased Prevalence of Chronic Conditions Requiring Radiation Therapies to Drive Market
Radiation therapy is one of the important modes of remedy employed for a diverse varieties of disease such as cancer. However, radiation treatment is often associated with several side effects caused due to the ionization of healthy cells in the process of targeting diseased cells. To mitigate these side effects, monitoring of the radiation dose, which refers to the quantity of radiation absorbed by the patient, is of high importance. An increasing awareness regarding the patient safety is compelling healthcare practitioners to employ effective measures for radiation dose management.
Ad Statistics
Times Displayed: 173689
Times Visited: 3172 For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
Get PDF Brochure for Research Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25394
The vast rise in the number of chronic diseases such as cardiovascular conditions, a variety of cancers, rising safety concerns, improving quality of patient care, and growing number of diagnostics screening test are expected to emerge as the key factors driving the global market for radiation dose management. The market is also expected to be positively influenced owing to the massive rise in government initiatives aimed at the improvement of healthcare infrastructure and the increased inclusion of advanced digital technologies in healthcare systems.
North America to Remain Most Promising Regional Market
Of the key applications of the global radiation dose management market, the oncology segment held the dominant share in 2016. The segment is also expected to continue to expand at a promising pace over the forecast period as well, holding a substantial share of the overall market over the report's forecast period, owing chiefly to the increasing number of cancer cases globally.
Request a Custom Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=25394
Geographically, the market in North America accounted for a dominant share in the global market in 2016 and continues to remain a regional market with highly promising growth opportunities. The promising expansion of the regional market is attributed to the well-established healthcare sector, presence of some of the world's leading medical device companies, and strong reimbursement policies.
